The Effect of Coffee on People with High Intensity Exercise and the Characteristics of Caffeine Metabolism

NCT ID: NCT06712667

Last Updated: 2025-02-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-23

Study Completion Date

2029-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this project is to explore the relationship between the effect of coffee on exercise performance and caffeine metabolism.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators will study the relationship between the impact of coffee on exercise and caffeine metabolism. The investigators will recruit healthy elite athletes. Participants will be forbidden to consume stimulant drinks such as coffee for 24 hours before the experiment. When the participants arrive at the lab on the day of the experiment, they will sign an informed consent form, a health history questionnaire and a daily coffee consumption questionnaire. Each participant does six rides, with one day of caffeine washout before each ride. In all trials, each participant will ride at the same time of day. Before riding, drink 200 ml water, decaffeinated coffee or coffee in random order, and the caffeine content of coffee is 200 mg. After 60 minutes of drinking, they start riding, after the completion of the riding, the subjects perceived and judged the perception between the baseline load and the comparison load. After the completion of the judgment, the next level of stimulus parameters will randomly generated to conduct the experiment. Each person conducted 6 groups of intervention experiments. Changes in average exercise performance, heart rate, electrocardiogram and body temperature will be observed after drinking decaffeinated coffee or coffee compared with drinking water. The concentration of caffeine and its metabolites in urine before and after drinking within 3 hours will be measured by liquid chromatography-mass spectrometry (LC-MS) or gas chromatography-mass spectrometry (GC-MS).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Water

The participants will drink 200 ml water.

Group Type PLACEBO_COMPARATOR

Caffeine content

Intervention Type OTHER

Participants will drink the same volume of water or coffee with different amounts of caffeine.

Decaffeinated coffee

The participants will drink 200 ml decaffeinated coffee.

Group Type EXPERIMENTAL

Caffeine content

Intervention Type OTHER

Participants will drink the same volume of water or coffee with different amounts of caffeine.

Coffee

The participants will drink 200 ml coffee, the caffeine content is 200 mg.

Group Type EXPERIMENTAL

Caffeine content

Intervention Type OTHER

Participants will drink the same volume of water or coffee with different amounts of caffeine.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Caffeine content

Participants will drink the same volume of water or coffee with different amounts of caffeine.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Healthy adults 18-40 years old

Exclusion Criteria

Diabetes Hypoglycemia Gout Osteoporosis Gastric ulcer Pancreatitis Intestinal obstruction Blood phobia Pathological hypo or hyper tension Impaired glucose tolerance Claustrophobia HIV,etc.
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

John R. Speakman

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

John R Speakman, PhD

Role: STUDY_CHAIR

Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences

Shenzhen, Guangdong, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

John R Speakman, PhD

Role: CONTACT

15810868669

Huanan Zhang, Master

Role: CONTACT

13371016641

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Huanan Zhang, Master

Role: primary

13371016641

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SIAT IRB240915H0915

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Interindividual Variation in Response to Green Coffee
NCT06204445 ACTIVE_NOT_RECRUITING NA
Caffeine, DNA and Cognition
NCT05806476 UNKNOWN NA
The Effects of Coffee
NCT00336271 COMPLETED